Literature DB >> 25290096

Utility of double-balloon enteroscopy in patients with left ventricular assist devices and obscure overt gastrointestinal bleeding.

Adam L Edwards1, Klaus Mönkemüller2, Salpy V Pamboukian3, James F George4, C M Wilcox2, Shajan Peter2.   

Abstract

Obscure overt gastrointestinal bleeding (OGIB) is a challenge in patients with left ventricular assist devices (LVADs). We evaluated the utility and safety of double-balloon enteroscopy (DBE) in patients with LVADs in an observational consecutive-patient cohort from a single tertiary referral center. Ten patients with LVADs underwent thirteen DBEs for obscure OGIB. The first OGIB event necessitating DBE occurred after a mean of 512 ± 363 days of LVAD support. All patients underwent DBE, eleven anterograde and two retrograde, with a mean insertion depth 176 ± 85 cm. Diagnostic yield was 69 % with the primary bleeding lesion most frequently found in the mid-bowel. The most common lesions were arteriovenous malformations. Therapeutic yield with argon plasma coagulation (APC), epinephrine injection, and/or hemoclip placement was 89 %. There were no procedure-related complications. DBE in patients with LVADs has good diagnostic yield and high therapeutic yield for obscure OGIB and is safe and well tolerated. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2014        PMID: 25290096     DOI: 10.1055/s-0034-1377512

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  8 in total

1.  The incidence, risk factors, and outcomes of gastrointestinal bleeding in patients with a left ventricular assist device: a Japanese single-center cohort study.

Authors:  Masatoshi Akiyama; Kou Sakatsume; Konosuke Sasaki; Satoshi Kawatsu; Ichiro Yoshioka; Goro Takahashi; Kiichiro Kumagai; Osamu Adachi; Yoshikatsu Saiki
Journal:  J Artif Organs       Date:  2019-11-08       Impact factor: 1.731

Review 2.  Gastrointestinal Bleeding Following LVAD Placement from Top to Bottom.

Authors:  Kelly Cushing; Vladimir Kushnir
Journal:  Dig Dis Sci       Date:  2016-03-26       Impact factor: 3.199

3.  Left Ventricular Assist Devices Impact Hospital Resource Utilization Without Affecting Patient Mortality in Gastrointestinal Bleeding.

Authors:  Feng Li; Alice Hinton; Alan Chen; Nishaki K Mehta; Samer Eldika; Cheng Zhang; Hisham Hussan; Darwin L Conwell; Somashekar G Krishna
Journal:  Dig Dis Sci       Date:  2016-11-17       Impact factor: 3.199

4.  Arteriosclerosis Is a Major Predictor of Small Bowel Vascular Lesions.

Authors:  Taiki Aoyama; Akira Fukumoto; Kenjiro Shigita; Naoki Asayama; Shinichi Mukai; Shinji Nagata
Journal:  Dig Dis Sci       Date:  2018-01-25       Impact factor: 3.199

5.  Video capsule endoscopy in left ventricular assist device recipients with obscure gastrointestinal bleeding.

Authors:  Surachai Amornsawadwattana; Michael Nassif; David Raymer; Shane LaRue; Chien-Huan Chen
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

6.  Safety and efficacy of single-balloon enteroscopy in management of gastrointestinal bleeding in patients with a left ventricular assist device.

Authors:  Abhinav Koul; Donald M Pham; Arjun Nanda; Kevin E Woods; Steven D Keilin
Journal:  Endosc Int Open       Date:  2017-03

Review 7.  Treatment of gastrointestinal bleeding in left ventricular assist devices: A comprehensive review.

Authors:  Srikanth Vedachalam; Gokulakrishnan Balasubramanian; Garrie J Haas; Somashekar G Krishna
Journal:  World J Gastroenterol       Date:  2020-05-28       Impact factor: 5.742

8.  Small bowel bleeding in patients with left ventricular assist device: outcomes of conservative therapy versus balloon-assisted enteroscopy.

Authors:  Badr Al-Bawardy; Sarah D Schettle; Emmanuel Gorospe; Louis M Wong Kee Song; Naveen L Pereira; Jeffrey A Alexander; David H Bruining; Nayantara Coelho-Prabhu; Jeff L Fidler; William J Mauermann; David W Barbara; Ross Dierkhising; Elizabeth Rajan
Journal:  Ann Gastroenterol       Date:  2018-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.